[1]
Xie, C. 2024. Controlling Relative miRNA level as Target Therapy of the BRCA Mutation and Its Challenges. Transactions on Materials, Biotechnology and Life Sciences. 3, (Mar. 2024), 186–189. DOI:https://doi.org/10.62051/v78q5822.